Lv3
230 积分 2023-09-24 加入
Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives
6天前
已完结
Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis
7天前
已完结
Hepatocellular carcinoma in China
28天前
已完结
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
29天前
已完结
Predictors of Liver Dysfunction After Transhepatic Arterial Chemo-embolization in Hepatocellular Carcinoma Patients
1个月前
已完结
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
1个月前
已完结
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach
1个月前
已完结
Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma
1个月前
已完结
Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab
1个月前
已完结
Impact of baseline liver function on survival outcomes in patients with unresectable hepatocellular carcinoma (uHCC) treated with camrelizumab + rivoceranib vs sorafenib: A post hoc analysis of study CARES-310
3个月前
已完结
皖公网安备34019202002308
